Investigational fibroblast growth factor receptor 2 antagonists in early phase clinical trials to treat solid tumors

AbstractIntroduction: Fibroblast growth factor receptor 2 (FGFR2) is a highly conserved transmembrane tyrosine kinase receptor. FGFR2 dysregulation occurs in numerous human solid tumors and overexp...